retatrutide weight loss efficacy Will Reta Rewrite Obesity? Lilly's triple agonist achieves 16.8%

The ideal candidate will also have a healthy endocrine system, not be pregnant or breastfeeding, and have no history of severe low blood sugar

We were particularly intrigued to investigate the potential link between incretin-based drugs, such as DPP-4 inhibitors and GLP-1RAs, and pancreatic cancer

Lost 48lbs total, only 6lbs muscle loss everything else fat

Diabetes Investigation 14 (2), 247258

Goh said will worsen over time without treatment

The SURMOUNT-4 trial for tirzepatide, which shares some receptor targets with retatrutide, showed that participants who stopped the drug regained about two-thirds of their lost weight within a year